Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Ascend Vitality vs HealthSource

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #390
Ascend Vitality

Ascend Vitality is a cash-pay GLP-1 telehealth provider offering compounded semaglutide (starting at $199/mo) and compounded tirzepatide (starting at $299/mo) as both weekly injectables and needle-free…

Marked down on: All medications are compounded — FDA does not review compounded drugs for safety/effectiveness

vs
Dispatch #31Desk pick
HealthSource

HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.

Marked down on: No physician names or clinical leadership disclosed on public pages

HealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 53/100 (C) for Ascend Vitality. Ascend Vitality still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Ascend Vitality

53/100

C

Overall

HealthSource

84/100

B

Price transparency

28
94

State access

24
86

Molecule range

83
77

Onboarding speed

68
79

Support responsiveness

69
85

Licensing & trust

74
69

The spec sheet

FieldAscend VitalityHealthSource
Semaglutide$199/mo (compounded)$199/mo (all doses, compounded)
Tirzepatide$299/mo (compounded)$299/mo (all doses, compounded)
CoverageCoverage not publishedAll 50 states
Brand-nameCompounded onlyCompounded only
Oral optionYesYes
Best forReaders who want cash-pay compounded semaglutide & tirzepatide, injection or daily tablet.Readers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.
Desk Score53/100C84/100B

The verdict

Desk pick — HealthSource

HealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 53/100 (C) for Ascend Vitality. Ascend Vitality still holds its ground where its strengths line up with yours.

Choose Ascend Vitality if…

Readers who want cash-pay compounded semaglutide & tirzepatide, injection or daily tablet.

$199/mo (compounded) sema · $299/mo (compounded) tirz · Coverage not published

Choose HealthSource if…

Readers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.

$199/mo (all doses, compounded) sema · $299/mo (all doses, compounded) tirz · All 50 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Ascend Vitality · HealthSource.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.